Startup database

Oncology

Detection, sequencing, treatment selection and survivorship, the vertical where precision medicine has moved furthest into routine care.

30 companies

Grail

Early cancer detection

Creates multi-cancer early detection blood tests to identify cancer before symptoms appear.

Public$2B raisedMenlo Park, United States

Caris Life Sciences

Cancer screening and diagnostics

Offers molecular profiling services to identify precise therapeutic options for cancer patients.

Growth$1.7B raisedIrving, United States

Tempus

Precision medicine platform

Signal 100

Provides data and AI-driven precision medicine solutions for oncology clinics and researchers.

Public$1.4B raisedChicago, United States

Freenome

Early cancer detection

Develops blood tests for early cancer detection using genomics and machine learning.

Series C+$1.4B raisedSouth San Francisco, United States

Guardant Health

Early cancer detection

Develops liquid biopsy blood tests for cancer detection, treatment selection, and monitoring.

Public$550M raisedRedwood City, United States

Delfi Diagnostics

Cancer screening and diagnostics

Develops liquid biopsy tests using fragmentomics to detect lung and other cancers early.

Series C+$335M raisedBaltimore, United States

Owkin

AI drug discovery

Applies federated learning and AI to biological data for drug discovery and diagnostics.

Series C+$304M raisedParis, France

ConcertAI

Real-world data and analytics

Provides real-world data and AI software solutions for oncology clinical development.

Growth$300M raisedCambridge, United States

BostonGene

Cancer screening and diagnostics

Performs integrated genomic and transcriptomic profiling of patient tumors and microenvironments.

Series B$250M raisedBoston, United States

Sophia Genetics

Precision medicine platform

Standardizes clinical genomic data using AI to support precision oncology worldwide.

Public$250M raisedSaint-Sulpice, Switzerland

Paige

AI digital pathology

Signal 100

Creates AI-native digital pathology software to assist pathologists in diagnosing cancer.

Series C+$220M raisedNew York, United States

Epic Sciences

Cancer screening and diagnostics

Analyses circulating tumor cells to provide actionable data for personalized cancer therapies.

Series C+$200M raisedSan Diego, United States

Mirxes

Cancer screening and diagnostics

Develops microRNA liquid biopsy tests for the early detection of gastric and other cancers.

Series C+$177M raisedSingapore

Thyme Care

Oncology care navigation

Signal 100

Provides oncology care navigation and support to improve patient outcomes and lower costs.

Series C+$175M raisedNashville, United States

Geneoscopy

Cancer screening and diagnostics

Develops non-invasive, stool-based RNA tests to detect colorectal cancer and precancerous lesions.

Series C+$115M raisedSt. Louis, United States

COTA

Real-world data and analytics

Translates complex clinical data into real-world evidence to improve oncology patient care.

Series C+$111M raisedBoston, United States

ArteraAI

Precision medicine platform

Signal 100

Develops AI prognostic tests to personalize cancer treatment plans and improve outcomes.

Series B$110M raisedSan Francisco, United States

Ibex Medical Analytics

AI-powered pathology diagnostics

Applies artificial intelligence to cancer diagnostics in digital pathology workflows.

Series C+$102M raisedTel Aviv, Israel

Karkinos Healthcare

Oncology care platform

Builds a distributed oncology network to improve cancer care delivery across India.

Series B$45M raisedMumbai, India

Lucence

Cancer screening and diagnostics

Develops ultra-sensitive liquid biopsy tests for multi-cancer early detection and profiling.

Series B$29M raisedSingapore

Jasper Health

Oncology care navigation

Offers a digital coaching and care coordination platform for cancer patients and caregivers.

Series A$27M raisedBoise, United States

Massive Bio

Clinical trial matching

Uses AI to match cancer patients with clinical trials globally, expanding access.

Series B$23M raisedNew York, United States

CancerIQ

Cancer risk assessment

Helps clinicians identify, track, and manage patients with high genetic risk of cancer.

Series B$22M raisedChicago, United States

Kheiron Medical Technologies

AI-powered radiology diagnostics

Deploys deep learning to assist radiologists in detecting early-stage breast cancer.

Series A$22M raisedLondon, United Kingdom

Belong.Life

Patient companion software

Creates personalized social networks and navigational apps for cancer patients and caregivers.

Series B$19M raisedTel Aviv, Israel

Mika Health

Patient companion software

Offers a digital therapeutic application designed to support cancer patients during therapy.

Series B$15M raisedBerlin, Germany

Outcomes4Me

Patient empowerment platform

Empowers cancer patients with personalized treatment navigation, symptom tracking, and clinical trials.

Series A$12M raisedBoston, United States

Vara

AI-powered radiology diagnostics

Operates an AI-driven mammography platform to make breast cancer screening globally accessible.

Series A$11M raisedBerlin, Germany

SkinVision

Cancer screening

Develops a regulated smartphone application for early detection and monitoring of skin cancer.

Series B$10M raisedAmsterdam, Netherlands

OncoHealth

Oncology benefit management

Provides digital health solutions and oncology utilization management software for health insurers.

GrowthUndisclosedAtlanta, United States